| ZARGLUVA BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1226012 05 Aug 2004 | on 25 Feb 2009 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants. | | 
